Talkspace (TALK) Competitors $2.60 +0.05 (+1.96%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$2.60 0.00 (0.00%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. NHC, TDOC, GRAL, VRDN, AHCO, CDNA, AGL, PNTG, AVAH, and FLGTShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include National HealthCare (NHC), Teladoc Health (TDOC), GRAIL (GRAL), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Agilon Health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors National HealthCare Teladoc Health GRAIL Viridian Therapeutics AdaptHealth CareDx Agilon Health The Pennant Group Aveanna Healthcare Fulgent Genetics Talkspace (NASDAQ:TALK) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends. Does the media refer more to TALK or NHC? In the previous week, National HealthCare had 1 more articles in the media than Talkspace. MarketBeat recorded 5 mentions for National HealthCare and 4 mentions for Talkspace. National HealthCare's average media sentiment score of 0.79 beat Talkspace's score of 0.26 indicating that National HealthCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral National HealthCare 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of TALK or NHC? 57.4% of Talkspace shares are owned by institutional investors. Comparatively, 56.4% of National HealthCare shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 15.0% of National HealthCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, TALK or NHC? National HealthCare has higher revenue and earnings than Talkspace. National HealthCare is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$194.36M2.24$1.15M$0.02130.00National HealthCare$1.37B1.08$66.80M$6.9213.90 Which has more volatility and risk, TALK or NHC? Talkspace has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Is TALK or NHC more profitable? National HealthCare has a net margin of 10.03% compared to Talkspace's net margin of 1.51%. National HealthCare's return on equity of 6.87% beat Talkspace's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.51% 2.54% 2.15% National HealthCare 10.03%6.87%4.68% Do analysts rate TALK or NHC? Talkspace currently has a consensus target price of $4.50, suggesting a potential upside of 73.08%. Given Talkspace's stronger consensus rating and higher probable upside, research analysts clearly believe Talkspace is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTalkspace beats National HealthCare on 9 of the 17 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$426.65M$1.96B$5.49B$9.45BDividend YieldN/AN/A4.01%4.03%P/E Ratio130.0736.7628.4719.90Price / Sales2.2415.31410.1985.18Price / Cash214.6252.9335.9658.29Price / Book3.778.728.365.67Net Income$1.15M-$63.59M$3.24B$258.18M7 Day Performance4.84%2.56%3.13%2.81%1 Month Performance-5.80%13.12%10.98%13.53%1 Year Performance18.18%6.57%34.54%17.68% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.5319 of 5 stars$2.60+2.0%$4.50+73.1%+21.5%$426.65M$194.36M130.07500NHCNational HealthCareN/A$103.17-0.1%N/A-23.6%$1.60B$1.37B12.9312,400High Trading VolumeTDOCTeladoc Health2.6387 of 5 stars$8.31-0.2%$9.65+16.2%-8.2%$1.46B$2.57B-1.405,500News CoverageUpcoming EarningsGRALGRAIL0.6239 of 5 stars$40.18-1.4%$31.50-21.6%+130.4%$1.45B$125.60M-0.661,360VRDNViridian Therapeutics3.2137 of 5 stars$17.14+0.6%$37.56+119.1%+13.2%$1.40B$300K-4.4550AHCOAdaptHealth4.1977 of 5 stars$9.17-0.5%$13.40+46.1%-14.6%$1.24B$3.26B16.0910,500Positive NewsCDNACareDx4.1778 of 5 stars$20.02-0.5%$30.33+51.5%-31.0%$1.11B$333.79M17.41740Upcoming EarningsAGLAgilon Health2.7573 of 5 stars$2.25+0.7%$4.71+110.0%-68.6%$929.32M$6.06B-3.811,076PNTGThe Pennant Group3.4158 of 5 stars$25.35+0.5%$34.60+36.5%-19.3%$873.81M$695.24M33.367,000AVAHAveanna Healthcare2.4187 of 5 stars$4.07+0.2%$5.20+27.8%+0.5%$794.03M$2.09B203.5033,500Analyst UpgradeFLGTFulgent Genetics3.8027 of 5 stars$19.12-0.8%$24.00+25.5%-16.6%$582.09M$292.45M-14.381,313Positive News Related Companies and Tools Related Companies National HealthCare Competitors Teladoc Health Competitors GRAIL Competitors Viridian Therapeutics Competitors AdaptHealth Competitors CareDx Competitors Agilon Health Competitors The Pennant Group Competitors Aveanna Healthcare Competitors Fulgent Genetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.